Omnipod 5 Insulin Pump Injury and Diabetic Ketoacidosis Lawsuit Lawyers

Omnipod 5 Insulin Pump Pods Recalled Following Reports of Serious Injuries

What Parker Waichman LLP Found

• The FDA designated the Omnipod 5 recall as a Class I recall, its most serious recall category.
• Defective internal tubing may leak insulin, causing dangerous underdelivery without warning.
• At least 29 serious injuries have been reported in connection with the recalled pods.
• Insulin underdelivery may lead to diabetic ketoacidosis, hospitalization, or other life-threatening complications.
• Patients injured after using recalled Omnipod 5 pods may have the right to pursue a product liability lawsuit.

The U.S. Food and Drug Administration (FDA) has announced a Class I recall involving certain Omnipod 5 insulin pump pods manufactured by Insulet after reports that defective devices may leak insulin and fail to deliver the medication patients depend on every day. A Class I recall is the FDA’s highest level of recall and is reserved for situations in which there is a reasonable probability that use of a product could cause serious injuries or death.

For people living with Type 1 diabetes, insulin delivery systems are not simply convenient medical devices. They perform an essential function that helps maintain safe blood glucose levels around the clock. Many patients rely on automated insulin delivery systems because they reduce the burden of frequent injections while helping minimize dangerous swings in blood sugar.

According to the FDA, certain Omnipod 5 pods contain manufacturing defects involving tiny tears inside the device’s internal tubing. Those tears may allow insulin to leak before reaching the patient. As a result, users may unknowingly receive significantly less insulin than prescribed.

The FDA has reported at least 29 serious injuries associated with the recalled pods. Although no deaths had been reported when the recall announcement was issued, regulators warned that continued use of the affected devices could result in life-threatening medical emergencies, including diabetic ketoacidosis.

Medical device recalls involving products used to treat chronic conditions often raise significant legal and medical questions because patients rely on manufacturers to produce devices that function consistently and safely. When a defective medical device allegedly fails to deliver life-sustaining treatment, the consequences may become catastrophic within hours.

Understanding the FDA Class I Recall

The FDA classifies recalls into three categories based upon the potential danger presented by the product.

A Class I recall is reserved for products that present the greatest threat to public health. According to the FDA, this designation means there is a reasonable probability that use of the product will cause serious adverse health consequences or death.

Not every medical device recall receives this designation. Many recalls involve labeling corrections or relatively minor issues. A Class I recall generally indicates that regulators believe the potential consequences are severe enough to require immediate action.

Because insulin is a life-sustaining medication, interruptions in delivery can rapidly become medical emergencies. Even temporary underdelivery may place some patients at significant risk depending on their individual medical condition, insulin requirements, and how quickly elevated blood sugar develops.

The FDA’s decision to classify the Omnipod 5 recall as Class I underscores the seriousness of the alleged manufacturing defect and the potential consequences for patients using the affected devices.

How the Omnipod 5 Automated Insulin Delivery System Works

The Omnipod 5 system is designed to provide continuous insulin delivery for individuals living with Type 1 diabetes. Unlike many traditional insulin pumps, the Omnipod 5 uses a tubeless wearable pod attached directly to the body.

The system communicates with continuous glucose monitoring technology to automatically adjust insulin delivery based on glucose readings throughout the day. Under normal operating conditions, the system evaluates glucose data approximately every five minutes and adjusts insulin administration to help maintain blood sugar within a target range.

This automated approach has made the Omnipod 5 a popular treatment option because it reduces many of the manual calculations traditionally required by insulin pump therapy.

Patients depend on the system to deliver insulin accurately without requiring constant monitoring. When that automated process is interrupted because of an undisclosed manufacturing defect, patients may not immediately recognize that insulin delivery has been compromised.

That delay in recognizing underdelivery can significantly increase the risk of severe hyperglycemia and diabetic ketoacidosis.

The Manufacturing Defect Behind the Recall

According to information released by Insulet and the FDA, the recalled pods may contain tiny tears within internal tubing that carries insulin through the device.

Although these tears may be microscopic, they can allow insulin to leak before reaching the patient. The patient may therefore receive less insulin than intended despite believing the device is functioning normally.

The recall also raises concerns because the system may not always detect the reduced insulin delivery.

Normally, insulin pump systems contain alarms intended to notify users when problems occur. However, according to the recall information, some defective pods may not generate an alarm even when insulin is leaking.

The defective pods may instead enter what is described as an Automated Delivery Restriction mode. In that condition, patients may continue wearing the device without realizing that insufficient insulin is being delivered.

Because insulin requirements vary throughout the day, even relatively brief interruptions in therapy can cause blood glucose levels to rise rapidly.

Patients who rely on automated systems often trust the technology to alert them when something goes wrong. If warnings fail to activate, valuable treatment time may be lost.

Why Insulin Underdelivery Can Become Life-Threatening

Insulin enables glucose to enter the body’s cells where it is used for energy. Without sufficient insulin, glucose remains in the bloodstream, causing blood sugar levels to rise.

As blood sugar continues increasing, the body begins breaking down fat for energy, producing acidic compounds known as ketones.

When ketones accumulate faster than the body can eliminate them, diabetic ketoacidosis (DKA) may develop.

DKA is considered a medical emergency because it can progress rapidly and affect multiple organ systems.

Common symptoms include:

• Excessive thirst
• Frequent urination
• Nausea and vomiting
• Abdominal pain
• Fruity-smelling breath
• Fatigue
• Rapid breathing
• Confusion
• Difficulty remaining awake
• Loss of consciousness

Without prompt treatment, diabetic ketoacidosis can lead to coma or death.

Hospital treatment frequently includes intravenous insulin, fluid replacement, electrolyte correction, and continuous monitoring.

For many patients, hospitalization results in substantial medical expenses, lost income, emotional distress, and disruption of everyday life.

Potential Risks Beyond the Individual Patient

The FDA also noted that insulin underdelivery may create hazards extending beyond the patient alone.

Individuals experiencing severe hyperglycemia or diabetic ketoacidosis may become confused, disoriented, or lose consciousness. If those events occur while driving, operating heavy machinery, or performing safety-sensitive work, additional people may be placed at risk.

Medical device manufacturers are expected to consider reasonably foreseeable risks associated with product failures. This includes not only direct medical complications but also secondary injuries resulting from sudden medical emergencies caused by defective devices.

Identifying Recalled Omnipod 5 Pods

Patients using the Omnipod 5 system should determine whether their pods are included in the recall.

According to the FDA, affected products include pods associated with the recalled Unique Device Identifier (UDI):

10385083000527

Patients should compare their packaging and product information with the FDA recall notice and Insulet’s expanded list of affected lots.

The recall has expanded since Insulet initially notified customers in March 2026. Some products added later include expiration dates that had already passed, making it important for patients to review the most current recall information rather than relying solely on earlier notices.

Patients currently wearing affected pods should contact their healthcare provider immediately if replacement devices are unavailable or if they experience symptoms consistent with insulin under-delivery.

Product Liability Claims Involving Defective Medical Devices

Medical device manufacturers have a legal responsibility to design, manufacture, test, and monitor products intended for patient use.

When a defective device allegedly causes injury, patients may be entitled to pursue compensation under product liability laws.

Depending upon the facts of an individual case, claims may involve allegations such as:

• Manufacturing defects
• Design defects
• Failure to provide adequate warnings
• Negligent quality control
• Failure to identify and correct known safety problems
• Breach of warranty

Each lawsuit requires a detailed investigation into the device’s manufacturing history, regulatory records, quality assurance procedures, adverse event reports, and medical documentation.

Evidence often includes hospital records, endocrinology records, insulin pump data, recall documentation, laboratory results, and expert medical opinions.

Damages That May Be Available After a Defective Insulin Pump Injury

Patients harmed by a defective insulin delivery system may suffer losses extending far beyond the initial hospitalization.

Potential damages may include:

• Emergency room expenses
• Hospitalization costs
• Intensive care treatment
• Physician and specialist care
• Prescription medication expenses
• Future medical treatment
• Lost wages
• Reduced earning capacity
• Pain and suffering
• Emotional distress
• Permanent injuries resulting from diabetic complications

If a recalled medical device contributes to a fatal outcome, surviving family members may also have legal rights under applicable wrongful death laws.

Every case depends upon its unique facts, the patient’s medical history, and the evidence connecting the recalled device to the injuries sustained.

Omnipod Insulin Pump Injury Lawsuit FAQs

Can someone file a lawsuit after suffering complications from a recalled Omnipod 5 insulin pump pod?

Potentially, yes. Patients who experienced diabetic ketoacidosis, severe hyperglycemia, hospitalization, or other complications after using a recalled pod may have legal claims if evidence shows the defective device contributed to their injuries. Product liability cases generally focus on whether a manufacturing defect, inadequate warnings, or other failures caused harm.

What injuries may qualify for an Omnipod 5 recall lawsuit?

Each case is different, but injuries may include diabetic ketoacidosis, prolonged hyperglycemia, hospitalization, emergency treatment, loss of consciousness, neurological complications from delayed treatment, or other medical problems resulting from insufficient insulin delivery. Medical records and documentation of the recalled device are often important pieces of evidence.

What if the insulin pump never sounded an alarm?

The recall information indicates that some defective pods may fail to generate an alarm despite leaking insulin. If a patient unknowingly received too little insulin because the warning system did not activate, that circumstance may become an important issue during a product liability investigation.

Does an FDA recall automatically mean someone has a lawsuit?

No. A recall does not automatically establish legal liability or guarantee compensation. Every claim depends on the specific facts, including the recalled product involved, the injuries sustained, medical evidence, and whether the defective device contributed to the patient’s condition. However, an FDA Class I recall may become significant evidence in a product liability case.

What compensation may be available after injuries caused by a defective insulin pump?

Depending on the circumstances, compensation may include medical expenses, hospitalization costs, future treatment, lost income, diminished earning capacity, pain and suffering, emotional distress, and other damages recognized under applicable law. The amount recoverable varies based on the severity of the injuries and the evidence supporting the claim.

Contact Parker Waichman LLP For A Free Case Review

A defective medical device can have life-changing consequences when it fails to deliver a medication that patients depend on every day. If a recalled Omnipod 5 insulin pump pod allegedly caused diabetic ketoacidosis, hospitalization, severe hyperglycemia, or other serious complications, it is important to understand the legal options that may be available.

Parker Waichman LLP represents individuals and families nationwide in product liability litigation involving dangerous medical devices and defective healthcare products. The firm offers free consultations to evaluate potential claims and explain the legal process.

Call 1-800-YOUR-LAWYER (1-800-968-7529) today for a free, no-obligation case evaluation. Regardless of your location or where your injury occurred, our nationwide product injury law firm is ready to assist you.